Literature DB >> 28031558

Lung cancer: ET - platinum therapy comes home.

Lisa Hutchinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 28031558     DOI： 10.1038/nrclinonc.2016.216

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Randomized Prospective Biomarker Trial of ERCC1 for Comparing Platinum and Nonplatinum Therapy in Advanced Non-Small-Cell Lung Cancer: ERCC1 Trial (ET).

Authors:  Siow Ming Lee; Mary Falzon; Fiona Blackhall; James Spicer; Marianne Nicolson; Abhro Chaudhuri; Gary Middleton; Samreen Ahmed; Jonathan Hicks; Barbara Crosse; Mark Napier; Julian M Singer; David Ferry; Conrad Lewanski; Martin Forster; Sally-Ann Rolls; Arrigo Capitanio; Robin Rudd; Natasha Iles; Yenting Ngai; Michael Gandy; Rachel Lillywhite; Allan Hackshaw
Journal:  J Clin Oncol       Date:  2016-11-28       Impact factor: 44.544
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.